ライフサイエンスコーパス: chest X-ray

1 te aortic calcification was present on prior chest X-ray.

2 uantiferon Gold (Q-G) positive with negative chest X-rays.

3 inspired fraction of oxygen (FiO2) ratio and chest X-rays.

4 IgE, IgA, and IgG; and abnormal results from chest x-rays.

5 n of recurrent disease was CEA testing (30), chest x-ray (12), colonoscopy (14), and other (40).

6 ed Chest CT-All DI consisted of (1) abnormal chest X-ray, (2) rapid deceleration mechanism, (3) distr

7 ted with reason for imaging (P<0.001), year (chest x-ray 67% in 2000-2004 vs. 49% in 2005-2009; P<0.0

8 ), computed tomography scan (23.6% v 26.4%), chest x-ray (7.3% v 12.1%), and colonoscopy (12.7% v 8.8

9 everity of sarcoidosis was assessed based on chest X-ray abnormalities.

10 examination-and might the radiologist with a chest X-ray and abdominal ultrasound do better?

11 (including cysticercosis and echinococcus), chest x-ray and abdominal ultrasound found no evidence o

12 ortality reduction among those randomized to chest x-ray and cytology.

13 tient with asthma to be afebrile with normal chest x-ray and white blood cell count.

14 nely evaluated by physical examination, ECG, chest X-ray, and 24-hour Holter.

15 , carcinoembryonic antigen (CEA) assessment, chest x-ray, and colonoscopy in detecting recurrent dise

16 amin intake, normal liver function, negative chest x-ray, and no other evidence of recurrence.

17 onary failure, with bilateral infiltrates on chest x-ray, and PaO2/fraction of inspired oxygen (FiO2)

18 had more bone scans, tumor antigen testing, chest x-rays, and chest/abdominal imaging than other wom

19 We measured bone scans, tumor antigen tests, chest x-rays, and other chest/abdominal imaging during 3

20 ry function tests, arterial blood gases, and chest X-rays, but the correlation with lung pathology is

21 s diagnosed by examining the posteroanterior chest X-rays by a radiologist and graded into four group

22 Chest x-rays, CBCs, and liver function tests are not rec

23 Use of chest X-ray, chest computed tomography scan, abdominal a

24 ical examination, liver function tests, CEA, chest X-ray, computed tomography scan of the abdomen, an

25 function studies, carcinoembryonic antigen, chest x-ray, computed tomography scans, and endoscopies

26 es were consistently lower than rates in the chest X-ray (CXR) arm.

27 patients, physical examination (PE) in 14%, chest x-ray (CXR) in 23%, and abdominal x-ray (KUB) in 7

28 mes were weight gain and an improvement in a chest X-ray (CXR) lesion assessed at 6 mo of treatment.

29 of mechanical ventilation (MV) and portable chest X-ray (CXR) measurements of lung length (LL) and s

30 Original readings of chest X-rays (CXR) and computerized tomography (CT) were

31 Chest radiography (chest x-ray [CXR] and chest computed tomography [CT]) is

32 he role of portable, anteroposterior, supine chest X-rays (CXRs) in distinguishing hydrostatic pulmon

33 Chest X-rays (CXRs) were conducted as standard care for

34 Rates of tumor antigen testing and chest x-rays decreased faster and chest/abdominal imagin

35 A chest x-ray demonstrated a right-upper-lobe opacity.

36 The analysis of chest X-ray doses was made on the basis of reports from

37 re doses delivered in low dose chest CT with chest X-ray doses.

38 lowed for 4 years with blood chemistries and chest x-ray every 3 months for year 1, every 4 months fo

39 ments in favor of lung cancer screening with chest x-ray examination and sputum cytology, a practice

40 predicted for LDCT may exceed those used in chest X-ray examinations by a factor of 4 to 12, dependi

41 Chest X-ray film and pulmonary function tests with diffu

42 reening tests began in the 1950s with annual chest x-ray films and sputum cytology but they resulted

43 e emphasizes that the abnormalities noted on chest x-ray films of the chest can be diagnostic of gian

44 on, and work of breathing) are negative, the chest x-ray findings are unlikely to be positive.

45 ed age, brain death, neurological diagnoses, chest x-ray findings, PaO2/FiO2, creatinine, alanine tra

46 tic lead malfunction can present with normal chest X-ray findings.

47 A chest x-ray followed by a chest computed tomography scan

48 included baseline questionnaire, spirometry, chest X-ray, food frequency questionnaire, and serum bet

49 mputed tomography as opposed to conventional chest x-ray for pulmonary surveillance is costly and pro

50 raphy and lung ultrasound are noninferior to chest x-ray for screening of pneumothorax and accurate c

51 itial fibrosis as identified on the baseline chest X-ray, from 0.9% to 2.4%, 10.8%, and 35.4% for Int

52 cted initially by CT scan without antecedent chest x-ray has increased considerably.

53 clinically used imaging strategies based on chest x-ray + head and neck MRI (CXR/MRI) and chest CT +

54 ng capacity of carbon monoxide (DL(CO)), and chest X-ray in 16 cases (5.2%); clinical history, DL(CO)

55 f effective radiation dose comparable with a chest x-ray in 2 views.

56 Chest X-ray is usually the first imaging modality to rai

57 Furthermore, chest x-rays, lung function, and PaO2/FIO2 ratios did no

58 Early in infection, an abnormal chest X ray, M. tuberculosis growth by gastric aspirate,

59 Follow-up on abnormal chest x-ray (odds ratio [OR], 2.07; 95% CI, 1.04 to 4.13

60 exposure history, a physical examination, a chest x-ray or computed tomography to rule out thymoma,

61 cts lung cancer 2 years earlier than routine chest x-ray or cytomorphology.

62 f correct management as at least a referral, chest X-ray or sputum test, 41% (111 of 274) SPs were co

63 (SPN) is a common radiologic abnormality on chest x-rays or computed tomography (CT) scans of the lu

64 CI, 1.3-3.2), pleural effusion on presenting chest x-ray (OR, 1.6; 95% CI, 1.1-2.4), and inpatient ca

65 ion, evidence for pulmonary edema on initial chest x-ray, or rearrest.

66 skin test conversion were required to have a chest x-ray performed and see a physician and were encou

67 the traditional imaging strategies based on chest x-ray plus head and neck MRI (CXR/MRI) or chest CT

68 load, 24.0%), and pulmonary function testing/chest x-ray (pulmonary dysfunction, 84.1%).

69 assessed by means of coronary venograms and chest x-rays recorded at the time of device implantation

70 l risk markers present (ADD score 0), 72 had chest x-rays recorded, of which 35 (48.6%) demonstrated

71 (71%), mild disease (76%), and mainly normal chest x-ray results.

72 rs of age the screened patients showed worse chest X-ray scores associated with earlier acquisition o

73 fessional societies call for routine staging chest x-rays (SCXR) for all patients with invasive cance

74 A preprocedure chest x-ray showed a right lower lobe infiltrate.

75 A chest x-ray showed bilateral hilar enlargement, thickeni

76 Postoperative portable chest x-rays showed the ECG method to position the cathe

77 ,377 male North American insulators for whom chest X-ray, spirometric, occupational, and smoking data

78 tested and volunteers underwent spirometry, chest x-ray study, and a bronchoalveolar lavage.

79 unity to examine factors captured on implant chest x-ray that correlate with risk for lead conductor

80 ment to investigate the result of a previous chest X-ray that showed bilateral mediastinal enlargemen

81 The detection rate for chest x-ray was 0.9%, the total cost was $120,934, and t

82 atio between medial doses in low dose CT and chest X-ray was 11.56.

83 Abnormal chest x-ray was the clue most frequently associated with

84 ed diuretic use and pulmonary edema on first chest x-ray, which resolved within 24 hours after admiss

85 dose reduction which would permit replacing chest X-ray with low dose CT in certain research screeni

86 inely capture anterior posterior and lateral chest x-rays within 2 weeks of implant.